Hyperfine Q4 revenue jumps, net loss narrows

Overview

• US portable brain MRI maker's Q4 revenue rose 128% yr/yr, net loss narrowed

• Full-year 2025 revenue grew 5.2%, gross margin improved to 50%

Outlook

• Hyperfine expects 2026 revenue of $20 to $22 mln

• Company expects 2026 cash burn of $26 to $28 mln, down 10% at midpoint

Result Drivers

• SYSTEM SALES GROWTH - Q4 revenue increase driven by higher sales of Swoop systems, with 16 units sold versus 9 a year earlier

• COST CONTROL - Lower research and development expenses helped narrow net loss

Company press release: ID:nBw3NCzqqa

Key Details

Analyst Coverage

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

• Wall Street's median 12-month price target for Hyperfine Inc is $1.65, about 26.9% above its March 17 closing price of $1.30

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.